Loading
Latest filing published 01 Dec 2025 for Pasithea Therapeutics Corp., €22k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Simon Dumesnil appears in our data through filings on Pasithea Therapeutics Corp. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 15 November 2022 to 28 November 2025.
On the market, this insider has only ever bought: 1 purchase, €22k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. 2025 to date brings 1 purchase and no sales.
On 1 December 2025 came the latest disclosure, an open-market purchase for €22k in Pasithea Therapeutics Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations